# Magnesium Sulfate in Adductor Canal Blocks

> **NCT02581683** · PHASE4 · COMPLETED · sponsor: **Queen's University** · enrollment: 130 (actual)

## Conditions studied

- Knee Arthroplasty

## Interventions

- **DRUG:** Magnesium Sulfate
- **DRUG:** Ropivacaine
- **OTHER:** Sham

## Key facts

- **NCT ID:** NCT02581683
- **Lead sponsor:** Queen's University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-09
- **Primary completion:** 2017-02
- **Final completion:** 2017-02
- **Target enrollment:** 130 (ACTUAL)
- **Last updated:** 2020-11-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02581683

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02581683, "Magnesium Sulfate in Adductor Canal Blocks". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02581683. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*